(INNF)
ABRILUMAB(INNE)
ABRILUMAB(INND)
ABRILUMAB(INNC)
IMMUNOGLOBULIN G2-KAPPA, ANTI-[HOMO SAPIENS INTEGRIN ITGA4 ITGB7 (INTEGRIN ALPHA4 (CD49D) BETA7, ALPHA4 BETA7, LYMPHOCYTE PEYER´S PATCH ADHESION MOLECULE 1, LPAM-1)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN (1-444) [HOMO SAPIENS VH(IGHV1- 24*01 (94.90%) -(IGHD)-IGHJ5*02) [8.8.11] (1-118) - IGHG2*01 (CH1 (119-216), HINGE (217-228), CH2 (229- 337), CH3 (338-442), CHS (443-444)) (119-444)], (132- 214')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-214') [HOMO SAPIENS V-KAPPA (IGKV1-12*01 (95.80%) -IGKJ1*01) [6.3.9] (1'-107') -IGKC*01 (108'-214')]; DIMER (220- 220'':221-221'':224-224'':227-227'')-TETRAKISDISULFIDE, RECOMMENDED INN: LIST 73(WHO)
ABRILUMABUM(INN)